Piotr Eder

Has grant

Assoc. Prof.

Poznan University of Medical Sciences

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Piotr Eder is an Associate Professor at Poznan University of Medical Sciences in Poland. His research focuses on inflammatory bowel disease (IBD), autoimmune pancreatitis, and the implications of host genetics and microbiota in gastrointestinal disorders. He has published recent articles highlighting diagnostic challenges, treatment efficacy, and the clinical implications of infections related to IBD.

Recent Grants

Grant: Close

Supertalenty w medycynie

Open Date: 2019-01-01

Close Date:

Grant: Close

Prize for the best publication

Open Date: 2018-01-01

Close Date:

Grant: Close

National Scholar Award

Open Date: 2012-01-01

Close Date:

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (20)

Ryszard Slomski

Institute of Human Genetics

POLAND

Piotr Eder

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (24)

Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational Study

Diagnostic Challenges of Cyclosporiasis in Chronic Diarrhea: A Case Study

Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study

Characteristics and Clinical Implications of Cytomegalovirus Infection in Patients with Drug-Resistant Ulcerative Colitis Undergoing Colectomy—Data from a Tertiary Referral Center in Poland

The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis

Helicobacter pylori infection is associated with increased accumulation of advanced glycation end products in the skin in patients with type 1 diabetes: A preliminary study

Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.

Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study

Multidisciplinary Perinatal Care in IBD

Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury

Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.

Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patients.

Scaffolds for drug delivery and tissue engineering: The role of genetics.

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.

Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review.

Effect of Hydrophilic Polymers on the Release Rate and Pharmacokinetics of Acyclovir Tablets Obtained by Wet Granulation: In Vitro and In Vivo Assays

Management of Adult Patients with Gastrointestinal Symptoms from Food Hypersensitivity—Narrative Review

Artificial Gastrointestinal Models for Nutraceuticals Research—Achievements and Challenges: A Practical Review

Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners—An Observational, Retrospective, Cross-Sectional Study Using Real-World Data

Obesity and the Brain

Iron Deficiency Anemia in Inflammatory Bowel Diseases—A Narrative Review

Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease

How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

Collaborators (20)

Ryszard Slomski

Dorota Zozulinska-Ziolkiewicz

Anna Pietrzak

Agnieszka Dobrowolska

Frank Hoentjen

Iwona Krela-Kaźmierczak

Andreas Blesl

Renata Talar-Wojnarowska

Marjo Campmans-Kuijpers

Bram Verstockt

Aleksandra Zielińska

Marek Hartleb

Izabela Miechowicz

Joanna Żuraszek- Szymańska

Gabriele Dragoni

Anna Maria Rychter

Katarzyna Korybalska

Edyta Zagorowicz

Szymon Hryhorowicz

Edoardo Savarino

Make your next move.